The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
123181984 12318198 4 F 20160915 20160429 20160929 EXP PHEH2016US010471 NOVARTIS 0.00 F Y 0.00000 20160929 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
123181984 12318198 1 PS ZOFRAN ONDANSETRON HYDROCHLORIDE 1 Transplacental MOTHER DOSE: 8 MG THRICE DAILY D 20103 TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
123181984 12318198 1 Foetal exposure during pregnancy

Outcome of event

Event ID CASEID OUTC COD
123181984 12318198 CA
123181984 12318198 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
123181984 12318198 Anhedonia
123181984 12318198 Anxiety
123181984 12318198 Blepharitis
123181984 12318198 Brain injury
123181984 12318198 Cardiac murmur
123181984 12318198 Cardiac ventricular disorder
123181984 12318198 Cardiomegaly
123181984 12318198 Cerebral atrophy
123181984 12318198 Cerebral palsy
123181984 12318198 Cerebral ventricle dilatation
123181984 12318198 Congenital anomaly
123181984 12318198 Constipation
123181984 12318198 Deformity
123181984 12318198 Developmental delay
123181984 12318198 Diplegia
123181984 12318198 Drooling
123181984 12318198 Dyspnoea
123181984 12318198 Emotional distress
123181984 12318198 Eye irritation
123181984 12318198 Foetal exposure during pregnancy
123181984 12318198 Gait disturbance
123181984 12318198 Haematemesis
123181984 12318198 Hypoxic-ischaemic encephalopathy
123181984 12318198 Injury
123181984 12318198 Joint dislocation
123181984 12318198 Language disorder
123181984 12318198 Left-to-right cardiac shunt
123181984 12318198 Microcephaly
123181984 12318198 Mitral valve incompetence
123181984 12318198 Muscle tone disorder
123181984 12318198 Ocular hyperaemia
123181984 12318198 Pain
123181984 12318198 Pancreatitis
123181984 12318198 Precocious puberty
123181984 12318198 Pyrexia
123181984 12318198 Quadriparesis
123181984 12318198 Quadriplegia
123181984 12318198 Respiratory arrest
123181984 12318198 Respiratory distress
123181984 12318198 Scoliosis
123181984 12318198 Seborrhoea
123181984 12318198 Seizure
123181984 12318198 Selective eating disorder
123181984 12318198 Self esteem decreased
123181984 12318198 Sleep apnoea syndrome
123181984 12318198 Speech disorder
123181984 12318198 Strabismus
123181984 12318198 Subdural haematoma
123181984 12318198 Transposition of the great vessels
123181984 12318198 Tricuspid valve incompetence
123181984 12318198 Upper airway obstruction
123181984 12318198 Ventricular hypertrophy
123181984 12318198 Ventricular septal defect
123181984 12318198 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found